SITAZEE M 50/500MG TAB

Sitazee M 50/500mg Tablet is a combination medication designed to manage type 2 diabetes effectively. Each tablet contains sitagliptin 50mg and metformin 500mg, working synergistically to regulate blood glucose levels. Sitagliptin enhances insulin secretion by inhibiting DPP-4 enzymes, while metformin reduces hepatic glucose production and improves insulin sensitivity. This dual-action formulation helps achieve better glycemic control with a single dose, improving treatment compliance. Suitable for patients requiring enhanced glucose management, Sitazee M offers a convenient therapeutic option when monotherapy proves insufficient.